NanoCor Therapeutics, Inc. ("NanoCor") is a biotechnology company founded to create the first viable intracellular genetic protein therapy for the treatment of Chronic Heart Failure ("CHF").
Company Details
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Alpharetta.
Nanocor Therapeutics, Inc. Questions
Nanocor Therapeutics, Inc.'s website is https://www.nanocortherapeutics.org
Nanocor Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/nanocor-therapeutics-inc.
Nanocor Therapeutics, Inc.'s industry is
Biotechnology Research
Nanocor Therapeutics, Inc.'s top competitors are
Trophogen,
Hepregen Corporation,
Nanospectra Biosciences,
Immunocellular Therapeutics Ltd,
Eragen Biosciences,
Foxkiser,
Mast Therapeutics, Inc.,
Baybio,
Opexa Therapeutics,
Aviragen Therapeutics.
Nanocor Therapeutics, Inc.'s categories are Biotechnology Research
